Immunome IMNM Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Immunome in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunome's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunome's total current liabilities?
- Immunome (IMNM) reported total current liabilities of $27.41M in Q1 2026.
- How has Immunome's total current liabilities changed year-over-year?
- Immunome's total current liabilities decreased by 11.0% year-over-year, from $30.8M to $27.41M.
- What is the long-term trend for Immunome's total current liabilities?
- Over 5 years (2020 to 2025), Immunome's total current liabilities has grown at a 71.4% compound annual growth rate (CAGR), from $3.04M to $44.99M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.